World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 October 2015
Main ID:  NCT02283918
Date of registration: 03/11/2014
Prospective Registration: No
Primary sponsor: Biogen
Public title: Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment Battery
Scientific title: Study to Establish Patient-Matched Population Norms for the MS-COG
Date of first enrolment: November 2014
Target sample size: 467
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02283918
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
France Italy United States
Contacts
Name:     Medical Director
Address: 
Telephone:
Email:
Affiliation:  Biogen
Key inclusion & exclusion criteria

Key Inclusion Criteria

1. Ability to understand the purpose and risks of the study and provide signed and dated
informed consent and authorization to use confidential health information in
accordance with national and local subject privacy regulations.

2. Must be in good health as determined by the Investigator, based on medical history,
physical examination, and Screening evaluations.

3. Must be a native language speaker of the country where the study is being conducted.

Key Exclusion Criteria:

1. Neurological illnesses/conditions, such as motor or vocal tics (including a diagnosis
of Tourette's syndrome), head trauma with significant loss of consciousness (>30
min), cerebral ischemia, carotid artery disease, epilepsy, brain tumor, dementia
(including mild cognitive impairment and Alzheimer's disease), chronic meningitis,
multiple sclerosis, pernicious anemia, normal-pressure hydrocephalus, HIV infection,
Parkinson's disease, and Huntington's disease.

2. Medical illnesses/conditions that may affect brain function, such as untreated
hypertension (blood pressure >140/100 mm Hg), cardiac disease, insulin-dependent
diabetes mellitus, endocrine disorders, renal disease, glaucoma, and chronic
obstructive pulmonary disease.

3. Major psychiatric disturbance according to the Diagnostic and Statistical Manual of
Mental Disorders, 5th edition (US) Axis I criteria [American Psychiatric Association
2013] and the International Statistical Classification of Diseases and Related Health
Problems, 10th revision Axis I criteria (Europe) [WHO 2010].

4. History of developmental disorders.

Note: Other protocol defined Inclusion/ Exclusion criteria may apply.



Age minimum: 25 Years
Age maximum: 58 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Healthy
Intervention(s)
Primary Outcome(s)
Symbol Digit Modalities Test (SDMT) Score [Time Frame: Day 1]
Selective Reminding Test (SRT) Score [Time Frame: Day 1]
Brief Visuospatial Memory Test-Revised (BVMT-R) Score [Time Frame: Day 1]
2- second and 3-second Paced Auditory Serial Addition Test (PASAT) Score [Time Frame: Day 1]
Secondary Outcome(s)
Secondary ID(s)
999MS005
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history